SEC Tracker
Get the app

Quince Therapeutics IRLA

Quince Therapeutics announces director changes

Form
8-K
Filed
Importance
Major
  1. Resigning Directors: June Bray, David Lamond, Christopher Senner
  2. Incoming Directors: Catherine Bonuccelli, Leone Patterson, James Valentine, Drayton Wise
  3. Effective Time: 2 business days after Oct 6, 2026 stockholder meeting
  4. Proposals include stock issuance and board changes

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Quince Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Veru VERU public float $64M, Mar 31, 2025, over 18 months old
  2. Lifevantage LFVN public float $64M, Dec 31, 2025
  3. Whitehawk Therapeutics WHWK public float $65M, Jun 30, 2025
  4. Medicinova MNOV public float $62M, Jun 30, 2025
  5. Corbus Pharmaceuticals Holdings CRBP public float $68M, Jun 30, 2025